Vanderbilt University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1873-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.vanderbilt.edu
Dopamine in Orthostatic Tolerance
Not Applicable
Terminated
- Conditions
- Postural Tachycardia Syndrome
- Interventions
- Dietary Supplement: dietary sodium
- First Posted Date
- 2008-09-08
- Last Posted Date
- 2015-06-15
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 22
- Registration Number
- NCT00748228
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
Autonomic Failure Patients for RNA Blood Sampling
Completed
- Conditions
- Multiple System AtrophyParkinson's Plus SyndromesPure Autonomic Failure
- First Posted Date
- 2008-08-27
- Last Posted Date
- 2016-10-18
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 30
- Registration Number
- NCT00742586
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q.3
Not Applicable
Completed
- Conditions
- Type 1 Diabetes
- Interventions
- Procedure: glucose clamp
- First Posted Date
- 2008-08-27
- Last Posted Date
- 2015-06-10
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 22
- Registration Number
- NCT00742521
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
Phase 1 Intravenous Citrulline for the Prevention of Bronchopulmonary Dysplasia in Preterm Infants
Phase 1
Withdrawn
- Conditions
- Bronchopulmonary Dysplasia
- First Posted Date
- 2008-08-27
- Last Posted Date
- 2011-12-30
- Lead Sponsor
- Vanderbilt University
- Registration Number
- NCT00742534
- Locations
- 🇺🇸
Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, United States
Metabolic Adaptation to Diabetes
Not Applicable
Completed
- Conditions
- Type 2 Diabetes
- Interventions
- Procedure: glucose clamp
- First Posted Date
- 2008-08-12
- Last Posted Date
- 2014-12-11
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 15
- Registration Number
- NCT00732862
Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis
Phase 2
Completed
- Conditions
- End Stage Renal Failure on DialysisComplication of Hemodialysis
- Interventions
- First Posted Date
- 2008-08-11
- Last Posted Date
- 2013-07-02
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 19
- Registration Number
- NCT00732069
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Aldosterone and Glucose Homeostasis
Not Applicable
Completed
- Conditions
- Diabetes Mellitus
- Interventions
- Drug: Vehicle Infusion (V)Other: High Sodium Diet (HS)Other: Low Sodium Diet (LS)
- First Posted Date
- 2008-08-11
- Last Posted Date
- 2017-04-06
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 34
- Registration Number
- NCT00732160
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Aspirin Resistance in Systemic Lupus Erythematosus (SLE)
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2017-08-07
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 70
- Registration Number
- NCT00731302
- Locations
- 🇺🇸
Vanderbilt University Medical School, Nashville, Tennessee, United States
🇺🇸Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Genetic Determinants of the Metabolism of Non-nucleoside Reverse Transcriptase Inhibitors
Phase 1
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2013-02-15
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 33
- Registration Number
- NCT00730223
Genetic Predictors of Raltegravir Penetration Into Cerebrospinal Fluid
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2015-03-03
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 40
- Registration Number
- NCT00729924
- Locations
- 🇺🇸
Vanderbilt Therapeutics Clinical Research Site, Nashville, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath